Advertisement
Health care leaders, government policy makers, health care providers,researchers, industry experts, academic leaders, and consumer and patientadvocacy groups will be among the more than 200 attendees gathering at OhioState University's Biomedical Research Tower to hear from national leaders inpersonalized health care. Industry leaders will discuss breakthroughs in gene-based information that helps individuals prevent disease, tailor therapies andmaintain health.
Advertisement
With a conference theme of "Translating Science to Personalized HealthCare," invited speakers include Linda Avey, co-founder and co-president,23andMe, Inc.; Geoffrey Ginsberg, director, Center of Geonomic Medicine, DukeInstitute for Genome Sciences & Policy, Duke University; Lawrence Lesko,director, Office of Clinical Pharmocology, Center for Drug Evaluation andResearch, U.S. Food and Drug Administration; Edison Liu, executive director,Genome Institutes of Singapore, professor of medicine, National University ofSingapore, executive director, Singapore Cancer Syndicate and executivedirector, Singapore Tissue Network; and Jeffrey Trent, president andscientific director, Translational Genomics Research Institute.
Personalized health care utilizes gene-based information to understandeach person's individual requirements for maintaining their health, preventingdisease and tailoring therapies. It is predictive and preventive, while alsoincorporating knowledge of an individual's environment, health-relatedbehaviors, culture and values.
"Personalized health care is emerging as one of the most significantdevelopments in health care in the 21st century," said Dr. Daniel Sedmak,executive director of The Ohio State University Center for Personalized HealthCare. "The conference will serve as a national platform to discuss theemerging trends and latest developments of personalized health care researchand its integration into personalized health care."
Complete information about the conference program, registration, keynotespeakers and personalized medicine are available at http://www.cphc.osu.edu/ .Speakers and expert panels will discuss: -- Opportunities and challenges of developing targeted therapies, genetic tests, biomarkers and other diagnostic tools to deliver personalized health care -- Strategies for increased collaboration between industry and academia -- The latest developments in cancer biomarkers discoveries and the current practice in personalized cancer therapy -- Challenges and opportunities of reforming current health care and creating a value-based, patient-centric health care system
SOURCE The Ohio State University Medical Center
